Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 14 | 2024 | 146 | 5.200 |
Why?
|
| Zebrafish Proteins | 9 | 2024 | 55 | 3.440 |
Why?
|
| Craniofacial Abnormalities | 6 | 2024 | 24 | 2.330 |
Why?
|
| Vitamin B 12 | 5 | 2024 | 23 | 1.810 |
Why?
|
| Cholesterol | 4 | 2020 | 232 | 1.560 |
Why?
|
| Host Cell Factor C1 | 5 | 2023 | 7 | 1.530 |
Why?
|
| Receptors, GABA-A | 2 | 2024 | 65 | 1.440 |
Why?
|
| Cell Differentiation | 7 | 2020 | 638 | 1.420 |
Why?
|
| Neural Crest | 5 | 2024 | 27 | 1.280 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2020 | 300 | 1.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 2 | 2019 | 3 | 1.140 |
Why?
|
| Terpenes | 2 | 2019 | 30 | 1.110 |
Why?
|
| Alleles | 3 | 2024 | 352 | 1.080 |
Why?
|
| Erythropoiesis | 2 | 2019 | 11 | 1.020 |
Why?
|
| Erythrocytes | 2 | 2019 | 126 | 0.950 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 2 | 2023 | 4 | 0.910 |
Why?
|
| Phenotype | 6 | 2024 | 780 | 0.870 |
Why?
|
| Mutation | 8 | 2024 | 1177 | 0.780 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1070 | 0.710 |
Why?
|
| Animals | 18 | 2026 | 16992 | 0.690 |
Why?
|
| Osteochondrodysplasias | 1 | 2021 | 2 | 0.690 |
Why?
|
| Dwarfism | 1 | 2021 | 2 | 0.690 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2011 | 5 | 0.690 |
Why?
|
| Mentors | 1 | 2021 | 145 | 0.650 |
Why?
|
| Protein Subunits | 1 | 2020 | 93 | 0.620 |
Why?
|
| Repressor Proteins | 3 | 2023 | 273 | 0.620 |
Why?
|
| Mutation, Missense | 1 | 2019 | 91 | 0.580 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 526 | 0.560 |
Why?
|
| Carrier Proteins | 2 | 2023 | 321 | 0.540 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2017 | 5 | 0.540 |
Why?
|
| Motor Activity | 1 | 2020 | 437 | 0.520 |
Why?
|
| Cell Biology | 1 | 2017 | 13 | 0.520 |
Why?
|
| Gene Expression | 1 | 2020 | 701 | 0.510 |
Why?
|
| Molecular Biology | 1 | 2017 | 47 | 0.510 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 54 | 0.500 |
Why?
|
| Minority Groups | 1 | 2021 | 690 | 0.490 |
Why?
|
| Learning | 1 | 2017 | 161 | 0.470 |
Why?
|
| RNA, Messenger | 3 | 2017 | 1271 | 0.470 |
Why?
|
| Students | 2 | 2021 | 626 | 0.460 |
Why?
|
| Chondrocytes | 3 | 2023 | 15 | 0.440 |
Why?
|
| Codon, Nonsense | 3 | 2024 | 23 | 0.430 |
Why?
|
| Mitochondria | 4 | 2026 | 523 | 0.430 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 74 | 0.420 |
Why?
|
| DNA | 1 | 2017 | 592 | 0.420 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2013 | 16 | 0.420 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 14 | 0.420 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1455 | 0.410 |
Why?
|
| Gene Knockdown Techniques | 4 | 2020 | 189 | 0.380 |
Why?
|
| Brain | 2 | 2020 | 1472 | 0.380 |
Why?
|
| Aging | 2 | 2026 | 783 | 0.320 |
Why?
|
| Flow Cytometry | 1 | 2011 | 411 | 0.310 |
Why?
|
| Mice | 7 | 2026 | 6644 | 0.310 |
Why?
|
| Cell Cycle | 1 | 2011 | 346 | 0.300 |
Why?
|
| Embryo, Nonmammalian | 2 | 2020 | 59 | 0.290 |
Why?
|
| GTP Phosphohydrolases | 2 | 2025 | 34 | 0.280 |
Why?
|
| Face | 2 | 2020 | 40 | 0.270 |
Why?
|
| Humans | 14 | 2025 | 43102 | 0.260 |
Why?
|
| Mitochondrial Proteins | 2 | 2025 | 118 | 0.260 |
Why?
|
| GATA1 Transcription Factor | 2 | 2019 | 2 | 0.260 |
Why?
|
| Branchial Region | 2 | 2017 | 5 | 0.250 |
Why?
|
| Body Patterning | 2 | 2017 | 25 | 0.240 |
Why?
|
| Transcription Factors | 2 | 2020 | 735 | 0.230 |
Why?
|
| Muscle, Skeletal | 2 | 2025 | 316 | 0.230 |
Why?
|
| Mitochondria, Muscle | 1 | 2025 | 25 | 0.230 |
Why?
|
| Cells, Cultured | 3 | 2024 | 1621 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 968 | 0.220 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2024 | 6 | 0.210 |
Why?
|
| Seizures | 1 | 2024 | 79 | 0.210 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 75 | 0.210 |
Why?
|
| Kidney | 1 | 2026 | 372 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 94 | 0.190 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 141 | 0.190 |
Why?
|
| Engineering | 1 | 2021 | 10 | 0.180 |
Why?
|
| Technology | 1 | 2021 | 29 | 0.180 |
Why?
|
| Mathematics | 1 | 2021 | 57 | 0.180 |
Why?
|
| Mandible | 1 | 2021 | 12 | 0.170 |
Why?
|
| Amino Acid Sequence | 3 | 2020 | 1180 | 0.170 |
Why?
|
| Collagen Type II | 1 | 2020 | 3 | 0.170 |
Why?
|
| SOXE Transcription Factors | 1 | 2020 | 3 | 0.170 |
Why?
|
| Faculty | 1 | 2021 | 105 | 0.170 |
Why?
|
| Cyclin D1 | 1 | 2020 | 44 | 0.170 |
Why?
|
| Endothelin-1 | 1 | 2020 | 57 | 0.160 |
Why?
|
| Oxidative Stress | 1 | 2026 | 1003 | 0.160 |
Why?
|
| Heterozygote | 1 | 2020 | 110 | 0.160 |
Why?
|
| Neurogenesis | 1 | 2020 | 63 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 118 | 0.160 |
Why?
|
| Texas | 1 | 2021 | 457 | 0.150 |
Why?
|
| Larva | 1 | 2020 | 133 | 0.150 |
Why?
|
| Locomotion | 1 | 2020 | 105 | 0.150 |
Why?
|
| Protein Binding | 3 | 2013 | 1082 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 1596 | 0.150 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 135 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2020 | 456 | 0.140 |
Why?
|
| Genotype | 1 | 2020 | 800 | 0.140 |
Why?
|
| Universities | 1 | 2021 | 559 | 0.140 |
Why?
|
| Base Sequence | 2 | 2017 | 983 | 0.130 |
Why?
|
| Dibenzocycloheptenes | 1 | 2017 | 2 | 0.130 |
Why?
|
| Benzophenones | 1 | 2017 | 11 | 0.130 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 25 | 0.130 |
Why?
|
| Piperidines | 1 | 2017 | 83 | 0.130 |
Why?
|
| Pyridines | 1 | 2017 | 139 | 0.120 |
Why?
|
| Female | 5 | 2025 | 24698 | 0.120 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 592 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2017 | 281 | 0.120 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 3 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2015 | 8 | 0.120 |
Why?
|
| Hematologic Diseases | 1 | 2015 | 13 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 38 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 458 | 0.110 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 72 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2014 | 79 | 0.110 |
Why?
|
| beta-Globins | 1 | 2013 | 2 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 209 | 0.100 |
Why?
|
| Hyperhomocysteinemia | 1 | 2013 | 4 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 9 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 16 | 0.100 |
Why?
|
| Hemoglobins | 1 | 2013 | 113 | 0.100 |
Why?
|
| Stem Cells | 1 | 2014 | 152 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 228 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 333 | 0.100 |
Why?
|
| Male | 6 | 2026 | 23409 | 0.100 |
Why?
|
| Neurons | 1 | 2020 | 1263 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 665 | 0.090 |
Why?
|
| Agammaglobulinemia | 1 | 2012 | 19 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 561 | 0.090 |
Why?
|
| Nocodazole | 1 | 2011 | 8 | 0.090 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2011 | 13 | 0.090 |
Why?
|
| Jurkat Cells | 1 | 2011 | 87 | 0.080 |
Why?
|
| Hydroxyurea | 1 | 2011 | 34 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 189 | 0.080 |
Why?
|
| Cell Movement | 1 | 2014 | 655 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 74 | 0.080 |
Why?
|
| RNA Interference | 1 | 2011 | 247 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2026 | 1869 | 0.080 |
Why?
|
| Chromatin | 1 | 2011 | 186 | 0.080 |
Why?
|
| Estrogens | 1 | 2011 | 203 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 652 | 0.080 |
Why?
|
| Child | 1 | 2017 | 3443 | 0.070 |
Why?
|
| Estradiol | 1 | 2011 | 268 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2011 | 883 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2017 | 2157 | 0.070 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2006 | 10 | 0.060 |
Why?
|
| Medicago sativa | 1 | 2006 | 9 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2006 | 31 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2006 | 82 | 0.060 |
Why?
|
| Sarcopenia | 1 | 2025 | 15 | 0.060 |
Why?
|
| Nitrogen | 1 | 2006 | 84 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2676 | 0.050 |
Why?
|
| Mitochondrial Membranes | 1 | 2023 | 41 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2024 | 108 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 532 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 112 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 95 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1019 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 191 | 0.050 |
Why?
|
| Lipids | 1 | 2024 | 256 | 0.050 |
Why?
|
| Calcium | 1 | 2024 | 491 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1723 | 0.040 |
Why?
|
| Exercise | 1 | 2025 | 692 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 2853 | 0.030 |
Why?
|
| Age of Onset | 1 | 2013 | 114 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 8214 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 94 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 77 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 92 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 671 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 436 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2012 | 132 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1542 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1175 | 0.020 |
Why?
|
| Middle Aged | 1 | 2025 | 12222 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 734 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1035 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1285 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 13872 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 678 | 0.020 |
Why?
|
| Glucuronidase | 1 | 2006 | 21 | 0.020 |
Why?
|
| Plants, Genetically Modified | 1 | 2006 | 51 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 148 | 0.010 |
Why?
|
| Nitrates | 1 | 2006 | 63 | 0.010 |
Why?
|
| Plant Leaves | 1 | 2006 | 136 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 132 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 296 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 532 | 0.010 |
Why?
|
| Plant Roots | 1 | 2006 | 180 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5080 | 0.010 |
Why?
|